Skip to content
VuFind
Login to My Library Account
All Fields
Title
Title Begins With
Journal Title
Journal Title Begins With
Author
Subject
Subject Begins With
Call Number
Government Document Number
Standard Number (ISBN, ISSN, etc.)
OCLC/Bibliographic Control Number Number
HRID
Browse Alphabetically: By Topic
Browse Alphabetically: By Author
Browse Alphabetically: By Title
Browse Alphabetically: By Call Number
Browse By Subject
Browse By Author
Browse By Title
Search
Advanced
Drug bioequivalence
Cite this
Text this
Email this
Print
Export Record
Export to EndNoteWeb
Export to Zotero / EndNote
Export to RIS
Save to List
Permanent link
Drug bioequivalence a report of the Office of Technology Assessment, Drug Bioequivalence Study Panel.
Show other versions (1)
Saved in:
Bibliographic Details
Corporate Author:
United States. Drug Bioequivalence Study Panel
Format:
Government Document
Microfilm
Book
Language:
English
Subjects:
Drugs
>
Bioavailability.
Drugs
>
Testing.
Holdings
Description
Other Versions (1)
Staff View
Showing
1 - 1
results of
1
Show all versions (2)
Search Result 1
Drug bioequivalence : a report of the Office of Technology Assessment, Drug Bioequivalence Study Panel.
Call Number:
Loading…
Located:
Loading…
Government Document
Book
Loading…
Save to List
Saved in:
Show all versions (2)
Similar Items
Drug bioequivalence : a report of the Office of Technology Assessment, Drug Bioequivalence Study Panel.
Drugs and biologics hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995-a consumer's perspective, June 19, 1995-FDA review process.
Published: (1995)
Drugs and biologics hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995-a consumer's perspective, June 19, 1995-FDA review process.
Published: (1995)
Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995-a consumer's prespective, June 19, 1995-FDA review process.
Published: (1995)
Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability
Published: (2009)